---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-25-000055"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T09:18:46.125984+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q1 revenue $693M, +5% ex-COVID/Donor; adjusted EPS $0.74 vs $0.44 YoY

## Summary
- Total revenue $693M, -3% reported due to lower COVID/Donor; ex-COVID/Donor +5% as reported and +6% constant currency.
- GAAP operating margin improved to 5% from (247%); adjusted EBITDA margin 23%, +450 bps driven by cost-savings.
- GAAP diluted loss per share $0.19 vs $25.50 loss prior (which included $1.74B goodwill impairment); adjusted EPS $0.74 vs $0.44.
- Labs revenue grew 5% as reported (7% constant currency); Donor Screening declined 62% as business winds down.
- Full-year 2025 guidance maintained: revenue $2.60-$2.81B, adjusted EBITDA $575-615M, adjusted diluted EPS $2.07-$2.57.

## SEC filing metadata
- accession: 0001906324-25-000055
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632425000055/0001906324-25-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632425000055/qdel-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-25-000055
- JSON: https://secwatch.observer/filing/0001906324-25-000055.json
- Plain text: https://secwatch.observer/filing/0001906324-25-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.